JP2012504619A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012504619A5 JP2012504619A5 JP2011530103A JP2011530103A JP2012504619A5 JP 2012504619 A5 JP2012504619 A5 JP 2012504619A5 JP 2011530103 A JP2011530103 A JP 2011530103A JP 2011530103 A JP2011530103 A JP 2011530103A JP 2012504619 A5 JP2012504619 A5 JP 2012504619A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- effective amount
- therapeutically effective
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10254908P | 2008-10-03 | 2008-10-03 | |
| US61/102,549 | 2008-10-03 | ||
| PCT/US2009/057512 WO2010039461A2 (en) | 2008-10-03 | 2009-09-18 | Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012504619A JP2012504619A (ja) | 2012-02-23 |
| JP2012504619A5 true JP2012504619A5 (enExample) | 2012-11-15 |
Family
ID=42074096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011530103A Withdrawn JP2012504619A (ja) | 2008-10-03 | 2009-09-18 | 肥満および糖尿病の有望な治療薬としてのグレリンｏ−アシルトランスフェラーゼ阻害剤の合成方法および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8772229B2 (enExample) |
| EP (1) | EP2340258A4 (enExample) |
| JP (1) | JP2012504619A (enExample) |
| AU (1) | AU2009298892A1 (enExample) |
| CA (1) | CA2739418A1 (enExample) |
| WO (1) | WO2010039461A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2761901C (en) | 2009-05-12 | 2019-08-13 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| AU2010313282A1 (en) | 2009-10-30 | 2012-05-24 | Ocera Therapeutics, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| AU2011268256B8 (en) | 2010-06-16 | 2016-12-22 | Mcgill University | Growth hormone secretatogue receptor antagonists and uses thereof |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2015010210A1 (en) * | 2013-07-24 | 2015-01-29 | Bucio Alfonso Abizaid | Compounds for regulating acylated ghrelin |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| LT3464336T (lt) | 2016-06-01 | 2022-05-10 | Athira Pharma, Inc. | Junginiai |
| CN108610337A (zh) * | 2018-05-30 | 2018-10-02 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| PH12022552277A1 (en) | 2020-02-28 | 2024-03-04 | Kallyope Inc | Gpr40 agonists |
| KR102333926B1 (ko) * | 2020-03-11 | 2021-12-02 | 연세대학교 산학협력단 | Tat 펩타이드 변이체를 유효성분으로 포함하는 대사질환의 예방 또는 치료용 조성물 |
| CN112014340A (zh) * | 2020-09-01 | 2020-12-01 | 广西玮美生物科技有限公司 | 非人灵长类动物胃饥饿素的检测方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1937262T (pt) | 2005-09-29 | 2019-08-21 | Ipsen Pharma Sas | Composição para utilização no tratamento de dismotilidade gastrointestinal |
| US8013015B2 (en) | 2008-10-02 | 2011-09-06 | Board Of Regents, The University Of Texas System | Small molecule inhibitors of ghrelin O-acyltransferase |
-
2009
- 2009-09-18 WO PCT/US2009/057512 patent/WO2010039461A2/en not_active Ceased
- 2009-09-18 AU AU2009298892A patent/AU2009298892A1/en not_active Abandoned
- 2009-09-18 US US13/122,438 patent/US8772229B2/en not_active Expired - Fee Related
- 2009-09-18 EP EP09818229A patent/EP2340258A4/en not_active Withdrawn
- 2009-09-18 JP JP2011530103A patent/JP2012504619A/ja not_active Withdrawn
- 2009-09-18 CA CA2739418A patent/CA2739418A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012504619A5 (enExample) | ||
| JP6549741B2 (ja) | ペグ化ｏｘｍ変異体 | |
| TWI689515B (zh) | Ｇｉｐ-ｇｌｐ-１雙重促效劑化合物及方法 | |
| RU2559320C2 (ru) | Новые аналоги глюкагона | |
| CA2837710C (en) | Pegylated oxyntomodulin conjugates with improved linkers | |
| CN105829339B (zh) | 胰高血糖素-glp-1-gip三重激动剂化合物 | |
| AU2017371516C1 (en) | Acylated GLP-1/GLP-2 dual agonists | |
| JP5635532B2 (ja) | グルカゴン類似体 | |
| JP5635529B2 (ja) | グルカゴン類似体 | |
| US9403894B2 (en) | Glucagon analogues | |
| JP5635530B2 (ja) | グルカゴン類似体 | |
| JP5635531B2 (ja) | グルカゴン類似体 | |
| JP5969461B2 (ja) | Ｇｌｐ−１受容体作動薬とガストリンとのペプチド複合体及びその使用 | |
| JP2019112437A (ja) | グルカゴン類似体 | |
| EP2773377B1 (en) | Glp-1 receptor agonist peptide gastrin conjugates | |
| JP5000663B2 (ja) | 神経ペプチド２受容体アゴニスト | |
| JP2016138127A (ja) | 心臓病の処置 | |
| KR20240055145A (ko) | 대사 및 간 장애의 치료를 위한 조성물 및 방법 | |
| WO2024193606A1 (zh) | 肠促胰岛素类似物及其应用 | |
| TW201632546A (zh) | 升糖素衍生物 | |
| WO2013098408A1 (en) | Glucagon and cck receptor agonist peptide conjugates | |
| KR20170129841A (ko) | 경구투여가 어려운 약물의 경구투여를 위한 신규한 약물 전달체 및 이의 제조방법 | |
| WO2017212494A1 (en) | Long-acting oxyntomodulin formulation and methods of producing and administering same | |
| WO2013185575A1 (zh) | 抑制hiv感染的小分子-多肽缀合物 | |
| WO2012016419A1 (zh) | Glp-1衍生物及其应用 |